Focus: AiM Medical Robotics develops MRI-compatible intraoperative robotic systems for minimally invasive procedures across ophthalmology, gastroenterology, metabolic diseases, and neurology. The company is a pre-revenue Series A biotech operating in the medical device/robotics segment.
Profile data last refreshed 10h ago · AI intelligence enriched 2w ago
Stable — net -3 jobs in 30d
1 added, 4 removed. Backfill posture.
Best suited for early-stage risk-tolerant technologists and operators seeking meaningful equity upside in a novel medtech platform; unsuitable for those seeking immediate revenue stability or mature organizational infrastructure.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for AiM Medical Robotics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from AiM Medical Robotics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo